HIMS stock gained nearly 6% on Wednesday, with some outlets suggesting the company's partnership with Novo may lead to a breakout. The stock has received positive attention from analysts, with Barclays raising its price target and Needham upgrading its rating to "buy". However, the stock's recent performance has been mixed, with some reports noting a significant decline over the past three months.